Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20448337 | 0.85 | LPAR3 (0.38) | LPAR2LPAR3 | |
| SCHEMBL8680466 | 0.85 | LPAR3 (0.38) | LPAR2LPAR3 | |
| SCHEMBL17686048 | 0.81 | S1PR2 (0.38) | — | |
| SCHEMBL2336204 | 0.78 | LPAR3 (0.35) | LPAR2LPAR3 | |
| SCHEMBL2398601 | 0.77 | ADRB2 (0.35) | — | |
| SCHEMBL375707 | 0.75 | LPAR2 (0.33) | LPAR2LPAR3 | |
| SCHEMBL375693 | 0.75 | LPAR2 (0.33) | LPAR2LPAR3 | |
| SCHEMBL375561 | 0.75 | LPAR2 (0.33) | LPAR2LPAR3 | |
| SCHEMBL16497342 | 0.74 | LMNA (0.35) | LPAR2LPAR3 | |
| SCHEMBL16496643 | 0.74 | LMNA (0.35) | LPAR2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140005432-A1 | PROCESS FOR PREPARING ORGANOSILANES | EVONIK DEGUSSA GMBH (DE) | 2014-01-02 | — | — | US | disclosed |
| EP-2408785-A1 | PROCESS FOR PREPARING ORGANOSILANES | Evonik Degussa GmbH (DE) | 2012-01-25 | — | — | EP | disclosed |
| WO-2010105434-A1 | PROCESS FOR PREPARING ORGANOSILANES | EVONIK DEGUSSA GMBH (DE) | 2010-09-23 | — | — | WO | disclosed |
| US-7339067-B2 | Process for producing mercaptoorganyl (alkoxysilane) | EVONIK DEGUSSA GMBH (DE) | 2008-03-04 | — | — | US | disclosed |
| US-20060052621-A1 | Process for producing mercaptoorganyl (alkoxysilane) | EVONIK DEGUSSA GMBH (DE) | 2006-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140005432-A1 | PROCESS FOR PREPARING ORGANOSILANES | MPST, STS, CYP2S1 | LPAR2 1773/4885LPAR3 3000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.